Comparing Nikki vs Yaz
| Nikki (drospirenone / ethinyl estradiol) | Yaz (drospirenone / ethinyl estradiol) |
|
|---|
| Nikki (drospirenone / ethinyl estradiol) | Yaz (drospirenone / ethinyl estradiol) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Premenstrual Dysphoric Disorder, Acne, Birth Control. Nikki may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Premenstrual Dysphoric Disorder, Acne, Birth Control. Yaz may also be used for purposes not listed in this medication guide. |
Related suggestions Birth Control
Premenstrual Dysphoric Disorder
|
|||||||||||||||
| More about Nikki (drospirenone / ethinyl estradiol) | More about Yaz (drospirenone / ethinyl estradiol) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Nikki has an average rating of 4.7 out of 10 from a total of 260 ratings on Drugs.com. 32% of reviewers reported a positive effect, while 49% reported a negative effect. |
Yaz has an average rating of 5.9 out of 10 from a total of 998 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 32% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Nikki side effects |
View all Yaz side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Lower cost generic approved | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Nikki prices |
View all Yaz prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other drospirenone / ethinyl estradiol brands include: Gianvi, Jasmiel, Lo-Zumandimine, Loryna, Melamisa, Ocella, Syeda, Yaela, Yasmin, Yaz, Zarah, Zumandimine View more | Other drospirenone / ethinyl estradiol brands include: Gianvi, Jasmiel, Lo-Zumandimine, Loryna, Melamisa, Nikki, Ocella, Syeda, Yaela, Yasmin, Zarah, Zumandimine View more | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
32.5 hours |
32.5 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 569 drugs are known to interact with Nikki:
|
A total of 569 drugs are known to interact with Yaz:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
|
|
||||||||||||||||
| First Approval Date | |||||||||||||||||
|
May 27, 2014 |
March 16, 2006 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.